Item List

The Future of Healthtech 2022
Market reset from 2021's blockbuster levels marked by flight to quality and early-stage investment
I think this is one of the best times to be starting a company and one of the best times to be building responsibly."
Hemant Taneja, Managing Partner General Catalyst
In just the past nine months, the healthtech industry has seen dramatic shifts. Venture capital investment and deal pace are slowing from their peak in 2021, with valuations lowering and check sizes decreasing.

Rising interest rates, inflation and global geopolitical factors all created record market volatility. Public healthtech companies saw their shares drop at record paces.